Different expression levels of Olig2, Nogo-A, Nestin and AQP4 have no independent prognostic impact in IDH-wildtype glioblastoma and show no distribution differences regarding age, clinical status and MGMT-promoter methylation status. The gene discussed is IDH2; the disease is glioblastoma.